OpenVSafe by OpenVAERS
Search V-safe

5AA-18375-07572

5 vaccinations 11 coded responses 38 check-ins 11 free-text entries 1 call case
Sex
Female
Age at first dose
66+
ZIP prefix
787 / TX
Registered
2021-05-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-29
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-08
    Registered in v-safe
  3. 2021-05-08
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · None
    Adult check-in
  4. 2021-05-13
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-05-20
    Dose 2 — Pfizer-BioNTech
  6. 2021-05-28
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-06-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  8. 2021-06-11
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-06-18
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-06-25
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-07-02
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-08-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-11-19
    Survey response — 6 months, dose 2
    MedDRA: Fatigue, Pain, Respiratory tract congestion, Vertigo — Feeling: Fair
    Free text: Fatigue, congestion, body aches, vertigo
    MedDRA releases: 2024-11 · check-in free text available
  14. 2021-12-10
    Dose 3 — Moderna
  15. 2021-12-13
    Survey response — days 1–6 daily, dose 3
    MedDRA: Catarrh, Dyspnoea, Upper-airway cough syndrome — Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Shortness of breath, postnasal drip, mucus buildup in throat
    MedDRA releases: 2024-11 · check-in free text available
  16. 2021-12-14
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dyspnoea, Respiratory tract congestion, Rhinorrhoea, Throat tightness — Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Congestion, runny nose, breathing feels constricted in throat
    MedDRA releases: 2024-11 · check-in free text available
  17. 2021-12-15
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dyspnoea, Increased upper airway secretion, Respiratory tract congestion, Throat tightness — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Shortness of breath, congestion, throat feels constricted -- coated in mucus
    MedDRA releases: 2024-11 · check-in free text available
  18. 2021-12-16
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dyspnoea, Respiratory tract congestion, Sneezing — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Congestion, sneezing, short of breath
    MedDRA releases: 2024-11 · check-in free text available
  19. 2021-12-17
    Survey response — day 7, dose 3
    MedDRA: Dyspnoea, Fatigue, Respiratory tract congestion — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Congestion, chronic fatigue, shortness of breatj
    MedDRA releases: 2024-11 · check-in free text available
  20. 2021-12-24
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  21. 2022-01-02
    Survey response — day 21, dose 3
    MedDRA: Fatigue, Hypopnoea, Respiratory tract congestion — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Chronic fatigue, shallow breathing, chest/throat congestion
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-01-10
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  23. 2022-01-14
    Health check-in — day 35, dose 3
    Feeling: Poor
    Adult check-in
  24. 2022-01-24
    Health check-in — day 42, dose 3
    Feeling: Poor
    Adult check-in
  25. 2022-03-13
    Survey response — 3 months, dose 3
    MedDRA: Alopecia, Dyspnoea, Localised infection, Malaise, Nail bed infection, Nausea, Skin disorder, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Toenail infection on big toe of each foot, scalp inflammation and hair loss, daily chronic nausea, resurgence of breathing difficulties (shortness of breath) · Healthcare visit (other): Appointments with podiatrist, dermatologist, internal medicine doctor have been made (too unwell to visit doctors until now)
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-03-13
    Report sent to call center — 3 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2022-03-17
  28. 2022-04-15
    Dose 4 — Pfizer-BioNTech
  29. 2022-04-21
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Redness · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  30. 2022-04-22
    Health check-in — day 7, dose 4
    Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  31. 2022-04-29
    Health check-in — day 14, dose 4
    Feeling: Fair
    Adult check-in
  32. 2022-05-06
    Health check-in — day 21, dose 4
    Feeling: Fair
    Adult check-in
  33. 2022-05-16
    Survey response — day 28, dose 4
    MedDRA: Catarrh, Dizziness, Respiratory disorder, Respiratory tract congestion — Feeling: Poor
    Free text: Chest congestion, lightheadedness, mucus buildup along respiratory tract --> mild, but noticeable, breathing issues
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-05-29
    Health check-in — day 42, dose 4
    Feeling: Fair
    Adult check-in
  35. 2022-07-17
    Survey response — 3 months, dose 4
    MedDRA: Alopecia, Dyspnoea, Fatigue, Nausea, Post-acute COVID-19 syndrome, Rash, Skin disorder — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Past 8 months (due to being a COVID long-hauler): hair loss, nausea (daily), skin problems (including rashes, peculiar hard bumps on arms, legs and face), shortness of breath, fatigue.
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-09-29
    Dose 5 — Moderna
  37. 2022-10-02
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · None
    Adult check-in
  38. 2022-10-05
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Rash, not including the immediate area around the injection site
    Adult check-in
  39. 2022-10-06
    Health check-in — day 7, dose 5
    Feeling: Fair · Site: Redness, Swelling · Rash, not including the immediate area around the injection site
    Adult check-in
  40. 2022-10-14
    Health check-in — day 14, dose 5
    Feeling: Fair
    Adult check-in
  41. 2022-10-21
    Survey response — day 21, dose 5
    MedDRA: Alopecia, Catarrh, Dyspnoea, Erythema, Fatigue, Pre-existing disease, Rash — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Long covid issues (since October 2021): Mucus buildup in throat & chest resulting in labored breathing. Chronic fatigue (again). Alopecia. Scalp rash/redness.
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-10-30
    Health check-in — day 28, dose 5
    Feeling: Fair
    Adult check-in
  43. 2022-11-03
    Health check-in — day 35, dose 5
    Feeling: Fair
    Adult check-in
  44. 2022-11-13
    Health check-in — day 42, dose 5
    Feeling: Fair
    Adult check-in
  45. 2022-12-30
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  46. 2023-03-30
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-29Pfizer-BioNTech
22021-05-20Pfizer-BioNTech
32021-12-10Moderna No
42022-04-15Pfizer-BioNTech No
52022-09-29Moderna No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 10 — 6 months, dose 2

2021-11-19

Symptoms: Fatigue, congestion, body aches, vertigo

Release 10 — days 1–6 daily, dose 3

2021-12-13

Systemic reaction (other): Shortness of breath, postnasal drip, mucus buildup in throat

2021-12-14

Systemic reaction (other): Congestion, runny nose, breathing feels constricted in throat

2021-12-15

Systemic reaction (other): Shortness of breath, congestion, throat feels constricted -- coated in mucus

2021-12-16

Systemic reaction (other): Congestion, sneezing, short of breath

Release 10 — day 7, dose 3

2021-12-17

Systemic reaction (other): Congestion, chronic fatigue, shortness of breatj

Release 10 — day 21, dose 3

2022-01-02

Symptoms: Chronic fatigue, shallow breathing, chest/throat congestion

Release 11 — 3 months, dose 3

2022-03-13

Symptoms: Toenail infection on big toe of each foot, scalp inflammation and hair loss, daily chronic nausea, resurgence of breathing difficulties (shortness of breath)
Healthcare visit (other): Appointments with podiatrist, dermatologist, internal medicine doctor have been made (too unwell to visit doctors until now)

Release 11 — day 28, dose 4

2022-05-16

Symptoms: Chest congestion, lightheadedness, mucus buildup along respiratory tract --> mild, but noticeable, breathing issues

Release 12 — 3 months, dose 4

2022-07-17

Symptoms: Past 8 months (due to being a COVID long-hauler): hair loss, nausea (daily), skin problems (including rashes, peculiar hard bumps on arms, legs and face), shortness of breath, fatigue.

Release 12 — day 21, dose 5

2022-10-21

Symptoms: Long covid issues (since October 2021): Mucus buildup in throat & chest resulting in labored breathing. Chronic fatigue (again). Alopecia. Scalp rash/redness.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMalaise · · ✓
HCVOUnevaluable event · · ✓
SDAlopecia · · ✓
SDCatarrh · · ✓
SDDizziness · · ✓
SDDyspnoea · · ✓
SDErythema · · ✓
SDFatigue · · ✓
SDHypopnoea · · ✓
SDLocalised infection · · ✓
SDNail bed infection · · ✓
SDNausea · · ✓
SDPain · · ✓
SDPost-acute COVID-19 syndrome · · ✓
SDPre-existing disease · · ✓
SDRash · · ✓
SDRespiratory disorder · · ✓
SDRespiratory tract congestion · · ✓
SDSkin disorder · · ✓
SDVertigo · · ✓
SROCatarrh · · ✓
SRODyspnoea · · ✓
SROFatigue · · ✓
SROIncreased upper airway secretion · · ✓
SRORespiratory tract congestion · · ✓
SRORhinorrhoea · · ✓
SROSneezing · · ✓
SROThroat tightness · · ✓
SROUpper-airway cough syndrome · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release